Cancer Stem Cells
boston-biomedical-nobuttons-3
boston-biomedical-nobuttons-4

About Us

Boston Biomedical is focused on the research and development of novel cancer therapeutics, and has developed a world-leading product pipeline targeting cancer stem cells.

Product Pipeline

home_pipeline_img (1)

BBI608 is in Phase III development for metastatic gastric cancer and is being studied in additional diseases.

Tell me more